Monday, August 1, 2016

UPDATE 1-Keryx withdraws 2016 forecast on renal drug supply disruption

Aug 1 (Reuters) - Keryx Biopharmaceuticals Inc said

it was withdrawing its full-year forecast due to issues related

to the production of its only approved drug, Auryxia.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)